Scientist: Platform RNA Sciences
Sail Biomedicines
Scientist: Platform RNA Sciences
Sail Biomedicines
In vivo programmable RNA CAR-T therapies
About Sail
Sail Biomedicines is pioneering the integrative design and deployment of fully programmable medicines to transform patient care. Sail’s platform combines first-in-class programmable circular RNA technology (Endless RNA™ or eRNA), and an industry-leading platform of programmable nanoparticles, utilizing natural components, to unlock comprehensive programming of medicines for the first time. By leveraging cutting-edge eRNA and nanoparticle deployment technology, Sail is also making unparalleled use of AI techniques to identify and design fully programmable medicines that are potent, targeted, versatile, and tunable. Sail was founded by Flagship Pioneering.
The Role
The Scientist, Platform RNA Sciences, will work on key projects to advance Sail’s first-in-class programmable circular RNA technology (Endless RNA™ or eRNA). This role works cross-functionally to perform hypothesis-driven experiments and high-throughput screens to improve our eRNA designs, with the goal to maximize circularization, and enhance RNA stability and translation. The successful candidate is self-motivated, curious and creative, thinks outside of the box and has a can-do mindset. The team looks forward to helping you strive in this exciting and fast-paced environment to make a real-world impact on patients’ lives.
Responsibilities
Qualifications
Preferred Qualifications
Salary Range: $98,000 - $125,000
Sail Biomedicines is an Equal Opportunity Employer. Sail does not discriminate based on race, religion, color, sex, gender identity, sexual orientation, age, national origin, veteran status, or any other status protected under federal, state, or local law.
In vivo programmable RNA CAR-T therapies
Sail Biomedicines creates programmable RNA medicines that enable in vivo CAR-T therapies for autoimmune diseases, turning the patient’s body into the site of T-cell engineering. Its platform combines Endless RNA circular RNA, a library of targeted nanoparticles for cell-specific delivery, and AI-powered design tools to program T cells inside the body. It differentiates from competitors by delivering and programming CAR-T cells in vivo rather than via ex vivo cell manufacturing, leveraging circular RNA and targeted nanoparticles, with support from its Flagship Pioneering lineage and a Johnson & Johnson collaboration. The goal is to provide scalable, durable immune resets and remission for immune-mediated diseases with broader, more accessible treatments.
Explore more opportunities at Sail Biomedicines